Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group

Nancy U. Lin, Eudocia Q. Lee, Hidefumi Aoyama, Igor J. Barani, Brigitta G. Baumert, Paul D. Brown, D. Ross Camidge, Susan M. Chang, Janet Dancey, Laurie E. Gaspar, Gordon J. Harris, F. Stephen Hodi, Steven N. Kalkanis, Kathleen R. Lambom, Mark E. Linskey, David R. Macdonald, Kim Margolin, Minesh P. Mehta, David Schiff, Riccardo SoffiettiJohn H. Suh, Martin J. van den Bent, Michael A. Vogelbaum, Jeffrey S. Wefel, Patrick Y. Wen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E396-E406
JournalLancet oncology
Volume14
Issue number10
DOIs
Publication statusPublished - Sep 2013

Cite this

Lin, N. U., Lee, E. Q., Aoyama, H., Barani, I. J., Baumert, B. G., Brown, P. D., Camidge, D. R., Chang, S. M., Dancey, J., Gaspar, L. E., Harris, G. J., Hodi, F. S., Kalkanis, S. N., Lambom, K. R., Linskey, M. E., Macdonald, D. R., Margolin, K., Mehta, M. P., Schiff, D., ... Wen, P. Y. (2013). Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. Lancet oncology, 14(10), E396-E406. https://doi.org/10.1016/S1470-2045(13)70311-5